Epineuron Technologies


Epineuron is a clinical-stage bioelectronic medicine company dedicated to revolutionizing nerve repair and regeneration. They develop innovative, drug-free, bioelectronic therapies to accelerate the healing of damaged peripheral nerves, with a focus on improving patient outcomes through cutting-edge research, technological advancements, and strategic partnerships. Their flagship product, PeriPulse™, is a Health Canada approved and FDA breakthrough device that delivers electrical stimulation to promote nerve regeneration, aiming to transform the treatment landscape for nerve injuries.

Industries

biotechnology
health-care
medical-device

Nr. of Employees

small (1-50)

Epineuron Technologies

1875 Buckhorn Gate Suite 602, Mississauga, ON L4W 5P1, Canada


Patents

Systems and methods for delivering neuroregenerative therapy

US-12616832-B2

View Details

Devices and methods for delivering neuroregenerative therapy

US-12318608-B2

View Details

Systems and methods for delivering neuroregenerative therapy

US-11247045-B2

View Details

Devices for delivering neuroregenerative therapy

US-11247044-B2

View Details

Systems and methods for delivering neuroregenerative therapy

US-10589089-B2

View Details

Products

Temporary wearable perioperative peripheral nerve stimulation system

A temporary, miniaturized wearable stimulator and conformable electrode system designed to deliver a short-duration electrical therapy directly to repaired peripheral nerves during or after surgery to accelerate regeneration.


Services

Support for multicenter clinical studies including study design, site engagement, trial registration, and execution of regulatory-grade trials.

In-service training and clinical implementation support to integrate a perioperative nerve stimulation therapy into surgical workflows.

Establishment and maintenance of QMS, support for regulatory submissions and audit readiness, and supplier quality management.

Expertise Areas

  • Bioelectronic medicine for peripheral nerve regeneration
  • Clinical trial management and regulatory-grade study execution
  • Medical device quality systems and regulatory compliance (ISO 13485, MDSAP)
  • Design control and device verification/validation
  • Show More (4)

Key Technologies

  • Brief electrical stimulation therapy (single-dose paradigm)
  • Wearable temporary neurostimulator systems
  • Shapeable conformable nerve electrodes
  • Clinical trial design (randomized, double-blind, sham-controlled)
  • Show More (6)

News & Updates

Safety and usability results published in Plastic and Reconstruction Surgery Global Open.

Results published in Bioelectronic Medicine showing potential in accelerating nerve regeneration.

Pivotal trial evaluating the safety and effectiveness of PeriPulse™.

Selected as one of 50 startups to accelerate healthcare innovation.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.